Evidence map›Paper›PMID 25834057›Full record

ArticleThe Journal of neuroscience : the official journal of the Society for Neuroscience2015

Neuronal-derived nitric oxide and somatodendritically released vasopressin regulate neurovascular coupling in the rat hypothalamic supraoptic nucleus.

Wenting Du, Javier E Stern, Jessica A Filosa

Open access · bronzeAbstract read
In one paragraph

Article in The Journal of neuroscience : the official journal of the Society for Neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
3.8field-weighted citation impact, top 7% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 29 citations in OpenAlex.

  1. Article
  2. Navigating Central Oxytocin Transport: Known Realms and Uncharted Territories.The Neuroscientist : a review journal bringing neurobiology, neurology and psychiatry · 2025
    Review
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Guidelines for the measurement of vascular function and structure in isolated arteries and veins.American journal of physiology. Heart and circulatory physiology · 2021
    Review
  9. Review
  10. Review
  11. Review
  12. Vascular and neural basis of the BOLD signal.Current opinion in neurobiology · 2019
    Review
  13. Review
  14. Article
  15. Article
  16. Review
  17. Article
  18. Effects of Voluntary Locomotion and Calcitonin Gene-Related Peptide on the Dynamics of Single Dural Vessels in Awake Mice.The Journal of neuroscience : the official journal of the Society for Neuroscience · 2016
    Article
  19. Role of neurons and glia in the CNS actions of the renin-angiotensin system in cardiovascular control.American journal of physiology. Regulatory, integrative and comparative physiology · 2015
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 2 institutions in 1 country.

Wenting DuDepartment of Physiology, Georgia Regents University, Augusta, Georgia 30912.
Javier E SternDepartment of Physiology, Georgia Regents University, Augusta, Georgia 30912.
Jessica A FilosaDepartment of Physiology, Georgia Regents University, Augusta, Georgia 30912 jfilosa@gru.edu.
Georgia Regents Medical Center · USAugusta University · US

Funding

Signals and targets underlying mechanisms for neurovascular coupling in the brainR01HL089067 · NHLBI · UNIVERSITY OF CINCINNATI · PI FILOSA, JESSICA A · 2007 to 2017
$3.2M
CENTRAL NEURONAL-GLIAL MECHANISMS AND NEUROHUMORAL ACTIVATION IN HYPERTENSIONR01HL112225 · NHLBI · GEORGIA STATE UNIVERSITY · PI STERN, JAVIER E · 2012 to 2015
$1.5M
NHLBI NIH HHS R01 HL089067NHLBI NIH HHS R01HL089067-02NHLBI NIH HHS R01 HL112225NHLBI NIH HHS R01HL112225
6 · The paper itself

Abstract

The classical model of neurovascular coupling (NVC) implies that activity-dependent axonal glutamate release at synapses evokes the production and release of vasoactive signals from both neurons and astrocytes, which dilate arterioles, increasing in turn cerebral blood flow (CBF) to areas with increased metabolic needs. However, whether this model is applicable to brain areas that also use less conventional neurotransmitters, such as neuropeptides, is currently unknown. To this end, we studied NVC in the rat hypothalamic magnocellular neurosecretory system (MNS) of the supraoptic nucleus (SON), in which dendritic release of neuropeptides, including vasopressin (VP), constitutes a key signaling modality influencing neuronal and network activity. Using a multidisciplinary approach, we investigated vasopressin-mediated vascular responses in SON arterioles of hypothalamic brain slices of Wistar or VP-eGFP Wistar rats. Bath-applied VP significantly constricted SON arterioles (Δ-41 ± 7%) via activation of the V1a receptor subtype. Vasoconstrictions were also observed in response to single VP neuronal stimulation (Δ-18 ± 2%), an effect prevented by V1a receptor blockade (V2255), supporting local dendritic VP release as the key signal mediating activity-dependent vasoconstrictions. Conversely, osmotically driven magnocellular neurosecretory neuronal population activity leads to a predominant nitric oxide-mediated vasodilation (Δ19 ± 2%). Activity-dependent vasodilations were followed by a VP-mediated vasoconstriction, which acted to limit the magnitude of the vasodilation and served to reset vascular tone following activity-dependent vasodilation. Together, our results unveiled a unique and complex form of NVC in the MNS, supporting a competitive balance between nitric oxide and activity-dependent dendritic released VP, in the generation of proper NVC responses.

Indexed as

AnimalsAntidiuretic Hormone Receptor AntagonistsArginine VasopressinArteriolesDendritesMaleNeuronsNeurosecretory SystemsNitric OxideRatsReceptors, VasopressinSupraoptic NucleusVasoconstrictionVasodilationAntidiuretic Hormone Receptor AntagonistsArginine VasopressinNitric OxideReceptors, VasopressinV1a vasopressin receptor, ratvasopressin, 1-(1-mercaptocyclohexaneacetic acid)-2-(O- methyl-L-tyrosine)-8-L-arginine-arterioledendritehypothalamusneurovascularnitric oxidevasopressin

Identifiers

PMID25834057
PMCPMC4381004
OpenAlexW2091886745

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.